BRPI0812942A2 - Composto, composição farmacêutica e uso de um composto - Google Patents
Composto, composição farmacêutica e uso de um compostoInfo
- Publication number
- BRPI0812942A2 BRPI0812942A2 BRPI0812942-8A2A BRPI0812942A BRPI0812942A2 BR PI0812942 A2 BRPI0812942 A2 BR PI0812942A2 BR PI0812942 A BRPI0812942 A BR PI0812942A BR PI0812942 A2 BRPI0812942 A2 BR PI0812942A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2007052301 | 2007-06-15 | ||
PCT/IB2008/052333 WO2008152603A1 (en) | 2007-06-15 | 2008-06-13 | 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0812942A2 true BRPI0812942A2 (pt) | 2014-12-16 |
BRPI0812942A8 BRPI0812942A8 (pt) | 2018-05-02 |
BRPI0812942B1 BRPI0812942B1 (pt) | 2018-11-21 |
Family
ID=39772866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0812942A BRPI0812942B1 (pt) | 2007-06-15 | 2008-06-13 | composto derivado de 3-amino-6 - (1-amino-etil) - tetra-hidropirano, composição farmacêutica e uso de referido composto. |
Country Status (15)
Country | Link |
---|---|
US (1) | US8193179B2 (pt) |
EP (1) | EP2167494B1 (pt) |
JP (1) | JP5274553B2 (pt) |
KR (1) | KR101538814B1 (pt) |
CN (1) | CN101711243B (pt) |
AR (1) | AR067008A1 (pt) |
AT (1) | ATE520687T1 (pt) |
AU (1) | AU2008263397B2 (pt) |
BR (1) | BRPI0812942B1 (pt) |
CA (1) | CA2689102C (pt) |
ES (1) | ES2370123T3 (pt) |
MX (1) | MX2009013254A (pt) |
PL (1) | PL2167494T3 (pt) |
TW (1) | TWI414290B (pt) |
WO (1) | WO2008152603A1 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2009215327A1 (en) | 2008-02-20 | 2009-08-27 | Actelion Pharmaceuticals Ltd | Azatricyclic antibiotic compounds |
CN102046603B (zh) * | 2008-06-03 | 2014-08-13 | 埃科特莱茵药品有限公司 | 作为抗细菌剂的[4-(1-氨基-乙基)-环己基]-甲基-胺及[6-(1-氨基-乙基)-四氢-吡喃-3-基]-甲基-胺衍生物 |
CN104151316B (zh) | 2008-10-07 | 2016-06-15 | 埃科特莱茵药品有限公司 | 三环噁唑烷酮抗生素化合物 |
SG172088A1 (en) * | 2008-12-12 | 2011-07-28 | Actelion Pharmaceuticals Ltd | 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives |
EP2748163B1 (en) | 2011-05-31 | 2016-04-20 | Actelion Pharmaceuticals Ltd. | Process for preparing synthetic intermediates which can be used for manufacturing antibiotics |
AU2012275499A1 (en) * | 2011-06-27 | 2013-12-19 | Kyorin Pharmaceutical Co., Ltd. | Bridged bicyclic compounds for the treatment of bacterial infections |
CN106083787B (zh) * | 2016-06-21 | 2018-05-04 | 济南川成医药科技开发有限公司 | 一种4-(2-氨乙基)四氢吡喃的合成方法 |
WO2018026877A1 (en) | 2016-08-05 | 2018-02-08 | Calitor Sciences, Llc | Process for preparing substituted quinolin-4-ol compounds |
TW201833120A (zh) | 2017-02-17 | 2018-09-16 | 瑞士商愛杜西亞製藥有限公司 | 芳基噁唑啶酮抗生素化合物 |
EP3665156A4 (en) | 2017-08-09 | 2021-04-28 | Denali Therapeutics Inc. | COMPOUNDS, COMPOSITIONS, AND PROCEDURES |
PL3676297T3 (pl) * | 2017-09-01 | 2023-12-11 | Denali Therapeutics Inc. | Związki, kompozycje i sposoby |
CN113518618A (zh) | 2019-02-13 | 2021-10-19 | 戴纳立制药公司 | 化合物、组合物及方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2816618B1 (fr) | 2000-11-15 | 2002-12-27 | Aventis Pharma Sa | Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent |
EP2239260A1 (de) * | 2002-10-10 | 2010-10-13 | Morphochem Aktiengesellschaft Für Kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
EP1778688A1 (en) * | 2004-07-22 | 2007-05-02 | Glaxo Group Limited | Antibacterial agents |
DE102004041163A1 (de) * | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
JP4887297B2 (ja) * | 2004-09-24 | 2012-02-29 | アクテリオン ファーマシューティカルズ リミテッド | 新規二環式抗生物質 |
JP5314244B2 (ja) | 2004-10-27 | 2013-10-16 | 富山化学工業株式会社 | 新規な含窒素複素環化合物およびその塩 |
CN101258157A (zh) | 2005-05-24 | 2008-09-03 | 阿斯利康(瑞典)有限公司 | 具有抗菌活性的氨基哌啶喹啉及其氮杂等构类似物 |
EP1981881B1 (en) * | 2006-01-26 | 2011-12-07 | Actelion Pharmaceuticals Ltd. | Tetrahydropyrane antibiotics |
WO2007105154A2 (en) * | 2006-03-10 | 2007-09-20 | Actelion Pharmaceuticals Ltd | Antibiotic compounds |
-
2008
- 2008-06-13 PL PL08763320T patent/PL2167494T3/pl unknown
- 2008-06-13 JP JP2010511771A patent/JP5274553B2/ja not_active Expired - Fee Related
- 2008-06-13 TW TW097122296A patent/TWI414290B/zh not_active IP Right Cessation
- 2008-06-13 CN CN2008800187896A patent/CN101711243B/zh not_active Expired - Fee Related
- 2008-06-13 AR ARP080102542A patent/AR067008A1/es unknown
- 2008-06-13 ES ES08763320T patent/ES2370123T3/es active Active
- 2008-06-13 CA CA2689102A patent/CA2689102C/en not_active Expired - Fee Related
- 2008-06-13 AU AU2008263397A patent/AU2008263397B2/en not_active Ceased
- 2008-06-13 US US12/664,828 patent/US8193179B2/en not_active Expired - Fee Related
- 2008-06-13 WO PCT/IB2008/052333 patent/WO2008152603A1/en active Application Filing
- 2008-06-13 BR BRPI0812942A patent/BRPI0812942B1/pt not_active IP Right Cessation
- 2008-06-13 KR KR1020107000842A patent/KR101538814B1/ko active IP Right Grant
- 2008-06-13 EP EP08763320A patent/EP2167494B1/en not_active Not-in-force
- 2008-06-13 MX MX2009013254A patent/MX2009013254A/es active IP Right Grant
- 2008-06-13 AT AT08763320T patent/ATE520687T1/de active
Also Published As
Publication number | Publication date |
---|---|
BRPI0812942B1 (pt) | 2018-11-21 |
PL2167494T3 (pl) | 2012-01-31 |
JP5274553B2 (ja) | 2013-08-28 |
EP2167494B1 (en) | 2011-08-17 |
JP2010529983A (ja) | 2010-09-02 |
MX2009013254A (es) | 2010-01-25 |
TWI414290B (zh) | 2013-11-11 |
ATE520687T1 (de) | 2011-09-15 |
US20100179135A1 (en) | 2010-07-15 |
RU2010101003A (ru) | 2011-07-20 |
BRPI0812942A8 (pt) | 2018-05-02 |
KR20100023031A (ko) | 2010-03-03 |
CN101711243B (zh) | 2013-01-09 |
US8193179B2 (en) | 2012-06-05 |
CN101711243A (zh) | 2010-05-19 |
CA2689102A1 (en) | 2008-12-18 |
AU2008263397A1 (en) | 2008-12-18 |
EP2167494A1 (en) | 2010-03-31 |
ES2370123T3 (es) | 2011-12-12 |
CA2689102C (en) | 2016-07-26 |
TW200906416A (en) | 2009-02-16 |
AR067008A1 (es) | 2009-09-30 |
AU2008263397B2 (en) | 2013-12-05 |
KR101538814B1 (ko) | 2015-07-22 |
WO2008152603A1 (en) | 2008-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0810696A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0919942A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0907562A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0921375A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0815709A2 (pt) | composro, composição farmacêutica, e, uso de um composto. | |
BRPI0810161A2 (pt) | Composto, preparação farmacêutica, composição farmacêutica, e, uso de um composto | |
BRPI0921879A2 (pt) | composto, composição farmacêutica , e, uso de um composto | |
BRPI0716171A2 (pt) | composto, composiÇço farmacÊutica e uso de um composto. | |
BRPI1008793A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
BRPI1016219A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0609802A2 (pt) | composto, composição farmacêutica e uso de um composto | |
BRPI0810019A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0917579A2 (pt) | composto, composição farmacêutica, métodos, e, uso de um composto | |
BRPI1007018A2 (pt) | composto, composição farmacêutica, e , uso de um composto. | |
BRPI0819696A2 (pt) | Compostos de derivados de 2-fenil-pirimidina, composição farmacêutica e uso de um composto | |
BRPI0821115A2 (pt) | Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto | |
BRPI1008906A2 (pt) | composto, composição farmacêutica, e, uso de um composto. | |
BRPI0812942A2 (pt) | Composto, composição farmacêutica e uso de um composto | |
BRPI0906937A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0917001A2 (pt) | composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica | |
BRPI0809977A2 (pt) | Uso de um composto, compostos e composição farmacêutica que o contém | |
BRPI0716698A2 (pt) | Composto, composição farmacêutica e uso de um composto | |
BRPI0614730A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0915134A2 (pt) | composto, e, uso de um composto | |
BRPI0919165A2 (pt) | composição farmacêutica,e, uso de um composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: IDORSIA PHARMACEUTICALS LTD (CH) |
|
B25L | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled |
Owner name: ACTELION PHARMACEUTICALS LTD (CH) |
|
B25C | Requirement related to requested transfer of rights |
Owner name: ACTELION PHARMACEUTICALS LTD (CH) |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: IDORSIA PHARMACEUTICALS LTD (CH) |
|
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/11/2018, OBSERVADAS AS CONDICOES LEGAIS. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 12A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2594 DE 24-09-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |